In recent trading, shares of Prometheus Biosciences Inc (Symbol: RXDX) have crossed above the average analyst 12-month target price of $58.55, changing hands for $58.79/share. When a stock reaches the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback